Volume 9, Number 8—August 2003

Research

Multidrug-Resistant Tuberculosis in HIV-Negative Patients, Buenos Aires, Argentina

Domingo Palmero* , Viviana Ritacco†, Martha Ambroggi‡, Marcela Natiello‡, Lucía Barrera†, Lilian Capone‡, Alicia Dambrosi‡, Martha Di Lonardo‡, Nélida Isola‡, Susana Poggi‡, Marisa Vescovo‡, and Eduardo Abbate‡

Author affiliations: *Hospital F. J. Muñiz, Buenos Aires, Argentina; †National Institute of Infectious Diseases “Carlos G. Malbran,” Buenos Aires, Argentina; ‡University of Buenos Aires, Buenos Aires, Argentina

Main Article

Figure 2

Figure 2. HIV-negative multidrug-resistant tuberculosis groups investigated. MDRTB, multidrug-resistant tuberculosis; RFLP, restriction fragment length polymorphism.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.